RSEM, LIMITED PARTNERSHIP
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Feb 01, 2018 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 52 Total Citation Count
- Apr 27, 2007 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0030,455 INHIBITION OF SEMA3A IN THE PREVENTION AND TREATMENT OF OCULAR HYPERPERMEABILITYOct 16, 17Feb 01, 18[A61K, C12Q, C12N, G01N, C07K]
2017/0307,619 MARKERS OF POOR PROGNOSIS ACUTE MYELOID LEUKEMIAS (AMLs) AND USES THEREOFMay 21, 15Oct 26, 17[C07H, C12Q, G01N, C40B]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9822367 Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeabilityFeb 21, 14Nov 21, 17[A61K, C12Q, C12P, C12N, G01N, A61P, C07K]
9757378 Methods to modulate acute myeloid leukemia stem/progenitor cell expansion and/or differentiationApr 04, 14Sep 12, 17[A61K, G01N]
9102981 Assessment and reduction of risk of graft-versus-host diseaseNov 20, 12Aug 11, 15[C07H, A61K, C12Q, C12P, G01N]
8993515 Peptidomimetics comprising N-amino cyclic urea residues and uses thereofJun 05, 13Mar 31, 15[A61K, C07K]
8039436 Mutated HOXB4 proteins with improved stability, and methods of use thereofMay 30, 08Oct 18, 11[A61K, C07K]
7971998 Apparatus and method for measuring a displacement within an eye in vivo in situ, and method of assessmentNov 14, 07Jul 05, 11[A61B]
7763425 Assessment and reduction of risk of graft-versus-host diseaseApr 27, 07Jul 27, 10[C12Q, C12P]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.